Primary Peritoneal Carcinoma — Trials

Primary Peritoneal Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

294 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 92
Recruiting: 35
Ph III recruiting: 5
Growth YoY: —
Industry share: 15%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (46)

clinicaltrialsPublishedShowing 1–6 of 6 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07674615	IMMU-132 in TROP-2 Overexpressed Advanced and Relapsed Ovarian Cancer	not yet recruiting	Phase 1	19	Shanghai Gynecologic Oncology GroupOTHER_GOV	1	Jun 30, 2026	clinicaltrials
NCT06726330	Risk-reducing Strategies, Including Fimbriectomy, in Women With a Germline Mutation Predisposing to Ovarian or Pelvic Cancer(FIMBRIMENOP)	not yet recruiting	N/A	1,100	Centre Oscar LambretOTHER	1	Mar 17, 2026